Once Burned, Twice Shy? Pharma Urged To Engage On Entitlement Reform
Executive Summary
Despite the current challenges to the ACA, the biopharmaceutical industry should engage proactively with lawmakers as Medicare and Medicaid face major reforms in the coming years, health policy experts urge at PhRMA’s annual meeting.